Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers

Clinical Trial ID NCT01325051

Rank	Title	Journal	Year	PubWeight™‹?›
1	Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.	N Engl J Med	2004	6.48
2	The challenge of viral reservoirs in HIV-1 infection.	Annu Rev Med	2002	4.73
3	Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.	J Acquir Immune Defic Syndr	2006	4.71
4	Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).	J Virol	2000	2.97
5	Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.	J Virol	2000	1.95
6	Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.	Arch Intern Med	1994	1.72
7	High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial.	Antimicrob Agents Chemother	2009	1.16
8	Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure.	AIDS	2013	1.08